Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
Go back to Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®| Pfizer Inc. (NYSE: PFE) | Delayed: 27.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.93 | 52 Week High | $37.39 | |||
| Open | $27.93 | 52 Week Low | $28.25 | |||
| Day High | $27.93 | P/E | 16.93 | |||
| Day Low | $27.93 | EPS | $1.65 | |||
| Volume | 23,653 | |||||
